Both in Biotechnology
Aligos Therapeutics vs Metagenomi Therapeutics
Over the past year ALGS returned −44.5% and MGX returned −68.8%; their daily moves had a correlation of 0.30.
ALGS −44.5% MGX −68.8%Growth of $1, one year, split-adjusted
| Metric | ALGS | MGX |
|---|---|---|
| Price | $5.17 | $0.8217 |
| Market cap | $32.3M | $31.0M |
| Today | +9.07% | +2.71% |
| 1 month | −8.0% | −27.3% |
| 6 months | −13.4% | −39.1% |
| Year to date | −44.5% | −49.3% |
| 1 year | −47.1% | −70.0% |
| Revenue growth (YoY) | +2778.5% | −103.0% |
| Gross margin | 100.0% | — |
| Net margin | −5.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.0× | 2.3× |
| Net cash | $30.3M | $120.7M |
| Dividend yield | — | — |
| Volatility (60d) | 96.1% | 45.4% |
| Short % of float | 12.7% | 5.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).